ALSO IN THIS MONTH'S ISSUE

• Companies To Watch: AltruBio

  : AltruBio’s new approach — regulating a checkpoint to mediate T cells in immune diseases — can surprise people more familiar with checkpoint-blocking cancer treatments now on the market.

• Genesis Of A Gene Therapy Manufacturing Giant

  Dr. Timothy Miller is trying to build one of the world’s largest AAV gene therapy manufacturing facilities. The cofounder and CEO of Columbus, OH-based Forge Biologics has been scratching the regenerative medicine leadership itch for quite a while now.

• VCs Breathe New Life Into Life Sciences Industrials

  The “industrials” or supplier sector of the biopharma industry, in a significant change from the past, is now receiving an extra financial boost from VC funding. Why should their biopharma customers care?

• Creating A Culture of Innovation In Any Size Organization

  A company’s size and culture play a large role in how it defines and executes innovation.